• 1. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 2. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 3. An approach to asymmetric synthesis of β-aryl alanines by Pd(0)-catalyzed cross-coupling and cyanate-to-isocyanate rearrangement?
  Piotr Szcze?niak,Sebastian Stecko RSC Adv., 2015,5, 30882-30888
• 4. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 5. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550

• Solvents and Organic Chemicals Organic Compounds Organic 1,3-dipolar compounds Allyl-type 1,3-dipolar organic compounds C-nitro compounds
• Solvents and Organic Chemicals Organic Compounds Organic 1,3-dipolar compounds Allyl-type 1,3-dipolar organic compounds Organic nitro compounds C-nitro compounds

Introduction to 2-chloro-6-methyl-5-nitropyridine-3,4-dicarbonitrile (CAS No. 98436-54-5)

2-chloro-6-methyl-5-nitropyridine-3,4-dicarbonitrile (CAS No. 98436-54-5) is a specialized heterocyclic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research due to its unique structural and chemical properties. This compound belongs to the pyridine class of nitrogen-containing heterocycles, which are widely recognized for their broad spectrum of biological activities and utility in drug development. The presence of multiple functional groups, including a chloro substituent, a methyl group, and two cyano groups, along with a nitro group, contributes to its complex reactivity and potential applications in synthetic chemistry.

The nitro group in 2-chloro-6-methyl-5-nitropyridine-3,4-dicarbonitrile plays a crucial role in its chemical behavior, serving as a versatile handle for further functionalization through reduction or nucleophilic substitution reactions. This characteristic makes it a valuable intermediate in the synthesis of more complex molecules, particularly in the development of novel therapeutic agents. The chloro substituent, on the other hand, enhances the electrophilicity of the pyridine ring, facilitating reactions such as nucleophilic aromatic substitution and cross-coupling reactions, which are fundamental in modern drug discovery.

The cyano groups at the 3 and 4 positions add another layer of reactivity, enabling further derivatization through hydrolysis or condensation reactions. These features collectively make 2-chloro-6-methyl-5-nitropyridine-3,4-dicarbonitrile a versatile building block for medicinal chemists seeking to develop new pharmacophores. Recent advancements in computational chemistry and molecular modeling have further highlighted its potential as a scaffold for designing drugs targeting various diseases.

In recent years, there has been growing interest in exploring the pharmacological properties of nitropyridine derivatives. Studies have demonstrated that such compounds can exhibit a wide range of biological activities, including antimicrobial, anti-inflammatory, and anticancer effects. The structural motif of 2-chloro-6-methyl-5-nitropyridine-3,4-dicarbonitrile has been investigated for its potential to interact with biological targets such as enzymes and receptors involved in disease pathways. For instance, modifications of this scaffold have shown promise in inhibiting kinases and other enzymes implicated in cancer progression.

One notable area of research involves the use of 2-chloro-6-methyl-5-nitropyridine-3,4-dicarbonitrile as a precursor in the synthesis of kinase inhibitors. Kinases are enzymes that play critical roles in cell signaling pathways, and their dysregulation is often associated with various diseases, particularly cancer. By leveraging the reactivity of the chloro, methyl, and cyano groups, researchers have been able to design analogs that selectively inhibit specific kinases while minimizing off-target effects. This approach aligns with the growing trend toward personalized medicine, where drugs are tailored to target the unique molecular profiles of individual patients.

The nitro group also contributes to the bioactivity of this compound by serving as a probe for understanding electronic effects and metabolic stability. Functionalization at this position can modulate the electronic properties of the pyridine ring, influencing how it interacts with biological targets. Additionally, the presence of multiple electron-withdrawing groups can enhance metabolic stability by reducing susceptibility to oxidative degradation by enzymes such as cytochrome P450 monooxygenases.

Another area where 2-chloro-6-methyl-5-nitropyridine-3,4-dicarbonitrile has shown promise is in the development of antimicrobial agents. Antibiotic resistance is a growing global health concern, necessitating the discovery of novel antimicrobial compounds. Pyridine derivatives have long been recognized for their antimicrobial properties due to their ability to disrupt bacterial cell membranes or interfere with essential metabolic pathways. The unique combination of functional groups in this compound makes it an attractive candidate for further exploration in this context.

Recent studies have also explored the potential use of 2-chloro-6-methyl-5-nitropyridine-3,4-dicarbonitrile in photodynamic therapy (PDT). PDT involves the use of photosensitizers that generate reactive oxygen species upon exposure to light, leading to selective destruction of target cells. The compound's ability to absorb light at specific wavelengths makes it a candidate photosensitizer or photosensitizer precursor. By incorporating it into drug formulations designed for PDT applications, researchers aim to develop more effective treatments for conditions such as cancer.

The synthesis and characterization of 2-chloro-6-methyl-5-nitropyridine-3,4-dicarbonitrile have been refined through advances in synthetic methodologies. Modern techniques such as transition-metal-catalyzed cross-coupling reactions and flow chemistry have enabled more efficient and scalable production processes. These advancements not only improve access to this compound but also allow for rapid screening and optimization of derivatives with enhanced biological activity.

In conclusion,2-chloro-6-methyl-5-nitropyridine-3,4-dicarbonitrile (CAS No. 98436-54-5) represents a fascinating example of how structural complexity can be leveraged to develop novel therapeutic agents. Its unique combination of functional groups makes it a valuable intermediate for synthetic chemists working on drug discovery programs targeting various diseases. As research continues to uncover new applications for this compound and its derivatives,2-chloro-6-methyl-5-nitropyridine-3,4-dicarbonitrile is poised to play an increasingly important role in pharmaceutical development.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)